Ohio med-device start-ups win grants
May 24, 2010 by MedCity News
Fluence Therapeutics Inc. and Dysphagia each land a $25,000 grant to develop a drug/device combination for psoriasis and a neurostimulation device for the eponymous swallowing disorder, respectively.
By Mary Vanac
Two northeast Ohio start-ups that are developing treatments for psoriasis and for people who have trouble swallowing are getting $25,000 grants from the Innovation Fund of the Lorain County Community College Foundation.
Fluence Therapeutics Inc. of Akron, which has licensed photodynamic therapy technology from University Hospitals Case Medical Center in Cleveland, is developing both a drug and a medical device to treat psoriasis. The company will use its grant for three things, CEO Warren Goldenberg said.
- Show full page
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- When regulators are ignored
- FDA Issues Draft Guidance to Help Companies Distinguish Between a Voluntary Medical Device Recall and a Product Enhancement
- Patient and family engagement in ICUs
- A day in the life: A pediatric neurosurgeon's vision
- Medical Device Tax: Are Conservatives' goals hampering repeal efforts?
- Personal health record use by adolescents
- Can Johnson & Johnson fire on all cylinders again?
- U.S. FDA to require proof of IEC 60601-1 3rd Edition in summer 2013
- A cure for coffee breath?
- A Goldilocks approach to leaky blood vessels: Not too stiff, but not too loose
Navigation
NEWS
Sunshine Heart seeks $25.5M in equity funding round | Wall Street Beat
Sunshine Heart raises $1.5 million of a hoped-for $25.5 million equity funding round.
J&J sues Shasta Technologies for logo infringement
J&J subsidiary Lifescan asks the courts to ban Shasta from using its logo, saying problems with...
Medical device tax: Theragenics, layoffs and the essence of the fight for repeal
Theragenics' recent rhetoric about the medical device tax captures many of the repeal movement's high...
FDA green-lights 1st HbA1cDx diabetes test | MassDevice.com On Call
U.S. healthcare regulators clear Roche's COBAS INTEGRA 800 Tina-quant HbA1cDx assay, the 1st HbA1c...
MassDevice.com +3 | The top 3 med-tech stories for May 23, 2013
If you read nothing else today, make sure you're still in the know with MassDevice +3.
